Launch of the MENA Regional Platform on Global Fund and Civil Society

The Global Fund in the MENA region The Global Fund against AIDS, Tuberculosis and Malaria (GFATM) is the largest financing institution that supports government and civil society in their response to HIV, TB and malaria in the Middle East and...

/ 12 January 2016

African Treatment Advocates Call on ViiV Healthcare to Unlock Access to Dolutegravir for North Africa Now

Harare, December 1st, 2015 Today, at the International Conference on AIDS and STIs in Africa (ICASA), treatment advocates and activists from all over Africa united to urge ViiV Healthcare to allow affordable access to an essential drug in four North...

/ 2 January 2016

Building Capacity on Intellectual Property, Free Trade Agreement and Access to Medicines Workshop

ATL MST – ITPC MENA WORKSHOP TUNISIA 16, 17 & 18 NOVEMBER 2015 One of the most pressing issues in the 21st century is the lack of availability of essential medicines to poor patients in underdeveloped and developing countries. The...

/ 20 November 2015

WHO Launches New HIV Treatment and Prevention Guidelines

The WHO has made two important new treatment recommendations that will affect all HIV treatment programmes. The recommendations are entitled the ’Early Release’ Guidelines on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. The recommendations in this...

/ 14 October 2015

Launch of Moroccan Generic Sofosbuvir: A Victory for the Wide-spread Use HCV Treatment in Morocco

According to the Ministry of Health, 625,000 people are infected by HCV, 1.6% of the general population of Morocco. Of those infected, 267,000 people have active chronic infection requiring treatment. Until recently, the management of HCV infection has been hampered...

/ 26 June 2015

Treatment Advocates Denounce Gilead’s Embargo against Thousands of Tunisians Suffering from HCV Infection

The Tunisian Association of Fight against STDs and AIDS (ATL Tunis) and the International Treatment Preparedness Coalition in MENA Region (ITPC-MENA) denounce the refusal of Gilead Sciences to make their drug against the Hepatitis C Virus (HCV), sofosbuvir, available to...

/ 20 May 2015

The first Middle East and North Africa Community Advisory Board (MENA-CAB)

Casablanca, Morocco, 28 June-01 July 2014 Despite the fact that HIV prevalence in the countries of the Middle East and North Africa is believed to be low at least among the General Population, the rate of increase of new cases...

/ 10 July 2014

Pharma Refuses to Ensure Access to Lifesaving Hepatitis C Treatment at Global Meeting

Bangkok, Thailand, February 28, 2014 —Thirty-eight activists from 22 countries joined forces at the first-ever Hepatitis C Virus (HCV) World Community Advisory Board (CAB) to demand equitable access to treatment for hepatitis C virus (HCV) from six multinational pharmaceutical companies....

/ 28 February 2014

HIV Activists from the MENA Region Call on Gulf States to Contribute to the 4th Replenishment of the Global Fund

November 30, 2013 - On the occasion of World AIDS Day 2013, HIV treatment activists from the MENA region called on wealthy Gulf States to join the Global Fund donor’s community sharing responsibility and engagement in a common mission to...

/ 30 November 2013

UNAIDS Report Suggests AIDS Epidemic Could End by 2030

BY NICHOLAS CIMARUSTI SEPTEMBER 27 2013 The UNAIDS released its 2013 global HIV/AIDS report Monday. Its figures estimate a possible end to the AIDS epidemic by 2030, which would also affect pharmaceutical companies. UNAIDS released the 2013 global HIV/AIDS report...

/ 30 September 2013